v3.25.4
STOCKHOLDERS DEFICIT (Details Narrative)
 1 Months Ended 12 Months Ended
Apr. 04, 2024
USD ($)
shares
Apr. 25, 2025
Apr. 26, 2022
shares
Jun. 30, 2025
USD ($)
$ / shares
shares
Sep. 11, 2024
shares
Jun. 30, 2024
$ / shares
shares
Apr. 12, 2024
$ / shares
shares
Mar. 07, 2024
$ / shares
shares
Purchase price | $       $ 522,000        
Common stock shares of Vitality RX     10,500,000          
Description of Vitality RX shareholders     50,000 shares of Series A Convertible Preferred Stock (which preferred stock is convertible into 5,000,000 shares of common stock)          
Preferred stock, shares authorized       500,000,000   500,000,000    
Preferred stock, shares par value | $ / shares       $ 0.000001   $ 0.000001    
Restricted common shares issued         2,000,000      
Common shares issued       59,838,963   23,882,297    
Common stock, shares par value | $ / shares       $ 0.000001   $ 0.000001    
Convertible Series A Preferred Stock [Member]                
Preferred stock, shares authorized       500,000,000        
Preferred stock, shares par value | $ / shares       $ 0.000001        
Number of preferred stock converted into common stock       100        
Series A Preferred Stock - Certificate of Designations [Member]                
Preferred stock, shares authorized       500,000,000        
Preferred stock, shares par value | $ / shares       $ 0.000001        
Conversion rate       100        
Conversion Notes Payable Common Shares [Member] | One Noteholders [Member]                
Convertible promissory note converted into common shares 50,075              
Convertible promissory notes | $ $ 11,350              
Asset Purchase Agreement [Member]                
Asset acquisition agreement description   (i) the issuance by the Company to Ticketbash’s owners of 20,000,000 shares of common stock and 1,151,500 shares of Series A Convertible Preferred Stock (which preferred stock is convertible into 115,150,000 shares of common stock) (such shares of common stock and preferred stock collectively the “Shares”), and additional shares as necessary to ensure that the shares issued constitute 60% of the total number of fully diluted shares of the Company, (ii) the future payment of two million dollars ($2,000,000) to Ticketbash based on net revenue and income milestones to be determined by the parties in the future, and (iii) the future payment of percentage royalties to Ticketbash based on aggregate revenues generated by the New Subsidiary as follows: 2% of revenue up to $15,000,000, 4% of revenue from $15,000,000-$25,000,000, and 5% of revenue in excess of $25,000,000            
Consultants [Member]                
Common shares issued             1,134,242 1,590,728
Common stock, shares par value | $ / shares             $ 0.000001 $ 0.000001